What is Gefitinib Tablets ?
Gefitinib is a medication available in tablet form and is used in the treatment of certain types of cancer, specifically non-small cell lung cancer (NSCLC). It falls under the category of targeted therapy drugs and is classified as an epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor.
Gefitinib Tablets Uses
- Gefitinib is primarily used for the treatment of non-small cell lung cancer (NSCLC), specifically in cases where the cancer has specific mutations in the epidermal growth factor receptor (EGFR) gene. It is generally used in advanced or metastatic NSCLC that has failed other forms of chemotherapy.
Gefitinib Tablets – Mechanism of Action and Pharmacology
Gefitinib is a targeted therapy drug that belongs to the EGFR tyrosine kinase inhibitors class. It works by inhibiting the activity of the EGFR protein, a receptor that is often overexpressed or mutated in certain types of cancer cells. EGFR is involved in signaling pathways that promote cell growth and proliferation. By blocking the activity of EGFR, gefitinib helps slow down the growth and spread of cancer cells.
Gefitinib Tablets – Side-effects
- Skin Rash: This is a common side effect and may manifest as a rash or acne-like skin changes. It’s usually mild to moderate in severity.
- Diarrhea: Diarrhea is another common side effect of gefitinib and may range from mild to severe.
- Nausea and Vomiting: Some individuals may experience nausea and vomiting while taking gefitinib.
